Urovant Sciences Ltd (UROV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,447 | -65,650 | -30,494 | -146,745 | -95,485 |
| Depreciation Amortization | 272 | 166 | 77 | 246 | 178 |
| Accounts payable and accrued liabilities | 1,920 | -1,096 | -1,459 | -336 | 463 |
| Other Working Capital | -7,076 | -1,586 | -2,525 | 18,443 | 8,659 |
| Other Operating Activity | 7,062 | 4,726 | 3,601 | 26,308 | 15,654 |
| Operating Cash Flow | $-110,269 | $-63,440 | $-30,800 | $-102,084 | $-70,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,082 | -448 | -104 | -769 | -732 |
| Other Investing Activity | -245 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,327 | $-448 | $-104 | $-769 | $-732 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 122,000 | 84,000 | 41,000 | 117,500 | 117,500 |
| Debt Repayment | N/A | N/A | N/A | -47,854 | N/A |
| Common Stock Issued | 11,079 | 4,457 | 1,536 | 796 | 718 |
| Other Financing Activity | -20 | 0 | 0 | -1,505 | -364 |
| Financing Cash Flow | $133,059 | $88,457 | $42,536 | $68,937 | $117,854 |
| Beginning Cash Position | 52,280 | 52,280 | 52,280 | 86,196 | 86,196 |
| End Cash Position | 73,743 | 76,849 | 63,912 | 52,280 | 132,787 |
| Net Cash Flow | $21,463 | $24,569 | $11,632 | $-33,916 | $46,591 |
| Free Cash Flow | |||||
| Operating Cash Flow | -110,269 | -63,440 | -30,800 | -102,084 | -70,531 |
| Capital Expenditure | -1,082 | -448 | -104 | -769 | -732 |
| Free Cash Flow | -111,351 | -63,888 | -30,904 | -102,853 | -71,263 |